Header Logo

Kamban Hirasen

Concepts (66)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antitubercular Agents
3
2024
322
0.810
 Why?
Drug Resistance, Bacterial
2
2018
135
0.720
 Why?
Rifampin
2
2018
197
0.690
 Why?
Tuberculosis
2
2023
543
0.560
 Why?
Anti-HIV Agents
5
2025
1324
0.480
 Why?
Tuberculosis, Multidrug-Resistant
3
2024
226
0.450
 Why?
HIV Infections
6
2025
5097
0.290
 Why?
Tuberculosis, Pulmonary
2
2022
324
0.270
 Why?
Adult
9
2025
5913
0.240
 Why?
Linezolid
1
2024
22
0.230
 Why?
Diarylquinolines
1
2024
39
0.230
 Why?
Male
9
2025
6754
0.220
 Why?
Adolescent
5
2025
2985
0.220
 Why?
Cost-Benefit Analysis
1
2024
253
0.210
 Why?
Health Care Costs
2
2024
115
0.210
 Why?
Humans
12
2025
14537
0.200
 Why?
Female
9
2025
9103
0.190
 Why?
Young Adult
4
2025
2498
0.190
 Why?
Pre-Exposure Prophylaxis
1
2025
196
0.190
 Why?
Drug-Related Side Effects and Adverse Reactions
2
2018
34
0.190
 Why?
Proportional Hazards Models
2
2018
163
0.190
 Why?
Middle Aged
5
2024
3601
0.180
 Why?
Depression
2
2018
121
0.170
 Why?
HIV-1
2
2018
1260
0.170
 Why?
Politics
1
2019
24
0.160
 Why?
South Africa
9
2025
7596
0.160
 Why?
Observational Studies as Topic
1
2018
21
0.160
 Why?
Kaplan-Meier Estimate
1
2018
106
0.150
 Why?
Drug Administration Schedule
1
2018
156
0.150
 Why?
Anemia
1
2018
41
0.150
 Why?
Prospective Studies
2
2018
1160
0.150
 Why?
Antiretroviral Therapy, Highly Active
2
2018
472
0.150
 Why?
Severity of Illness Index
1
2018
253
0.140
 Why?
Medication Adherence
1
2018
151
0.140
 Why?
Patient Compliance
1
2017
120
0.130
 Why?
Treatment Outcome
4
2019
889
0.120
 Why?
Anti-Retroviral Agents
1
2018
551
0.110
 Why?
Treatment Failure
3
2018
175
0.110
 Why?
Viral Load
3
2018
819
0.080
 Why?
Public Sector
2
2022
82
0.080
 Why?
Retrospective Studies
2
2025
799
0.080
 Why?
CD4 Lymphocyte Count
2
2018
656
0.060
 Why?
Cohort Studies
2
2018
967
0.060
 Why?
Administration, Oral
1
2025
127
0.060
 Why?
Homosexuality, Male
1
2025
52
0.060
 Why?
Nitroimidazoles
1
2024
24
0.060
 Why?
Drug Therapy, Combination
1
2024
279
0.060
 Why?
Sex Workers
1
2025
116
0.050
 Why?
Gambia
1
2022
13
0.050
 Why?
Income
1
2022
85
0.050
 Why?
Health Expenditures
1
2022
39
0.050
 Why?
Delivery of Health Care
1
2025
239
0.050
 Why?
Health Personnel
1
2023
231
0.050
 Why?
Follow-Up Studies
1
2018
370
0.040
 Why?
Disclosure
1
2017
25
0.040
 Why?
Public Health
1
2018
124
0.030
 Why?
Child
1
2023
2242
0.030
 Why?
Self Report
1
2017
114
0.030
 Why?
Hospitals
1
2016
103
0.030
 Why?
Risk Assessment
1
2017
225
0.030
 Why?
Sexual Partners
1
2017
215
0.030
 Why?
Case-Control Studies
1
2017
480
0.030
 Why?
Socioeconomic Factors
1
2017
411
0.030
 Why?
Drug Resistance, Viral
1
2017
278
0.030
 Why?
Time Factors
1
2016
507
0.030
 Why?
Prevalence
1
2018
1192
0.030
 Why?
Hirasen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (66)
Explore
_
Co-Authors (13)
Explore
_
Similar People (60)
Explore
_